Document Detail


Fetal fibronectin as a selection criterion for induction of term labor.
MedLine Citation:
PMID:  7503193     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We examined whether the presence of fetal fibronectin in cervicovaginal secretions can be used as a selection criterion for induction of labor at term. STUDY DESIGN: Cervicovaginal secretions of 64 women who were scheduled for induction of labor were examined for fetal fibronectin and divided into group A (positive for fibronectin) and group B (negative for fibronectin). Both groups were examined for Bishop score, the number of prostaglandin tablets administered, and the interval between induction of labor and delivery. RESULTS: In group A the interval between induction of labor and delivery was significantly shorter (p < 0.0001) than in group B. The number of prostaglandin tablets administered to group A was likewise significantly lower (p < 0.0001). Unsuccessful induction of labor only occurred in women with fibronectin-negative cervicovaginal secretions. CONCLUSION: The assessment of the fibronectin content of cervicovaginal secretions constitutes a viable instrument in the decision-making process preceding induction of labor.
Authors:
R Ahner; C Egarter; H Kiss; K Heinzl; R Zeillinger; C Schatten; A Dormeier; P Husslein
Related Documents :
6476023 - Placenta previa: aggressive expectant management.
12320903 - Job displacement effects of canadian immigrants by country of origin and occupation.
20925453 - Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrol...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  173     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1995 Nov 
Date Detail:
Created Date:  1996-01-16     Completed Date:  1996-01-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1513-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / analysis
Cervix Uteri / secretion
Delivery, Obstetric
Dinoprostone / administration & dosage
Female
Fibronectins / analysis*
Humans
Immunoenzyme Techniques
Infant, Newborn
Labor, Induced*
Patient Selection
Pregnancy
Regression Analysis
Sensitivity and Specificity
Statistics, Nonparametric
Tablets
Vagina / secretion
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Fibronectins; 0/Tablets; 363-24-6/Dinoprostone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of...
Next Document:  Oral terbutaline in the outpatient management of preterm labor.